PDF) Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study
Diffuse Large B-cell Lymphoma Prognosis Calculator
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by Santosh Khanal, Arjun Gampala et al.
Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial - Annals of Oncology
Diffuse large B cell lymphoma: Outlook, stages, treatment
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurately Predict Survival Risk And Improve Treatment Decisions
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy - Transplantation and Cellular Therapy, Official Publication of the American Society
Diffuse Large B-cell Lymphoma Prognosis Calculator
Follicular Lymphoma International Prognostic Index (FLIPI). Online calculator | ClinCaseQuest
Diffuse Large B-Cell Lymphoma Prognosis (R-IPI) | QxMD
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma – Karyopharm Therapeutics
Novel prognostic scoring system for diffuse large B-cell lymphoma
R/R International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B
Clinical Management Updates in Mantle Cell Lymphoma
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Age-standardized incidence rates over time for Australian adults with... | Download Scientific Diagram
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Diffuse large B cell lymphoma: Outlook, stages, treatment
